Outcome Following Surgical Therapy for Gastrointestinal Stromal Tumors

Journal of Gastrointestinal Surgery

Volumn 10, Issue 8, 2006, Pages 1099-1105

  Gupta, Maneesh ^a   Sheppard, Brett C ^a   Corless, Christopher L ^a   MacDonell, Karen R ^a   Blanke, Charles D ^a   Billingsley, Kevin G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Gastrointestinal stromal tumors; gastrointestinal tract; imatinib mesylate; KIT

Indexed keywords

STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ARTICLE; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33748457495     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2006.05.014     Document Type: Article

References (17)

1. Heinrich M.C., Corless C.L., Duensing A., et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299 (2003) 708-710
2. Hirota S., Isozaki K., Moriyama Y., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279 (1998) 577-580
3. Kindblom L.G., Remotti H.E., Aldenborg F., and Meis-Kindblom I.M. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152 (1998) 1259-1269
4. Corless C.L., Fletcher J.A., and Heinrich M.C. Biology of gastrointestinal stromal tumors. J Clin Oncol 22 (2004) 3813-3825
5. Ng E.H., Pollock R.E., Munsell M.F., Atkinson E.N., and Romsdahl M.M. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 215 (1992) 68-77
6. DeMatteo R.P., Lewis J.J., Leung D., Mudan S.S., Woodruff J.M., and Brennan M.F. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 231 (2000) 51-58
7. Evans H.L. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years. Cancer 56 (1985) 2242-2250
8. Miettinen M., Sarlomo-Rikala M., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 24 (2000) 1339-1352
9. Miettinen M., Majidi M., and Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): A review. Eur J Cancer 38 Suppl 5 (2002) S39-S51
10. Aparicio T., Boige V., Sabourin J.C., et al. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. Eur J Surg Oncol 30 (2004) 1098-1103
11. Miettinen M., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors of the stomach: A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29 (2005) 52-68
12. Nilsson B., Bumming P., Meis-Kindblom J.M., et al. Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-A population-based study in western Sweden. Cancer 103 (2005) 821-829
13. Fletcher C.D., Berman J.J., Corless C., et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 33 (2002) 459-465
14. Greenson J.K. Gastrointestinal stromal tumors and other mesenchymal lesions of the gut. Mod Pathol 16 (2003) 366-375
15. Singer S., Rubin B.P., Lux M.L., et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 20 (2002) 3898-3905
16. Besana-Ciani I., Boni L., Dionigi G., Benevento A., and Dionigi R. Outcome and long term results of surgical resection for gastrointestinal stromal tumors (GIST). Scand J Surg 92 (2003) 195-199
17. Bauer S., Hartmann J.T., de Wit M., et al. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Int J Cancer 117 (2005) 316-325